Aktiespot

Zhejiang Jolly Pharmaceutical Co.,LTD (ZHEJIANG JOLLY PHARMACEUTICAL C) aksje

300181.SZ

Stengt
¥13.49-0.02 (-0.15%)
Laster graf...

ZHEJIANG JOLLY PHARMACEUTICAL C

Åpning13.57
Høy13.71
Lav13.45
Volum6.91M
P/E14.35
Markedsverdi9.46B
52-ukers høy21.07
52-ukers lav13.45
Gj.sn. volum10.03M
Utbytte2.59%
Beta0.14
EPS0.94

Om Zhejiang Jolly Pharmaceutical Co.,LTD (ZHEJIANG JOLLY PHARMACEUTICAL C) aksje

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, it offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, the company provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, it offers materials, such as cephalosporin sinensis, fermented cordyceps, and Wuling powders. The company also invests and participates in the medical services of Deqing No.3 People's Hospital. Zhejiang Jolly Pharmaceutical Co.,LTD was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. The company was founded in 1995 and is based in Huzhou, China.

Selskapsinformasjon

Børs: Shenzhen (SHZ)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Generelt
Adresse:
No. 388, Zhiyuan North Road
313200 Huzhou, China
Telefon: + 86 57 2828 1088

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
23.00
70.5%
Gjennomsnittlig kursmål
23.00
70.5%
Median kursmål
23.00
70.5%
Høyeste kursmål
23.00
70.5%

Andre ser også på: